AAAAAA

   
Results: 1-4 |
Results: 4
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial
Authors: Daniel, DG Potkin, SG Reeves, KR Swift, RH Harrigan, EP
Citation: Dg. Daniel et al., Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial, PSYCHOPHAR, 155(2), 2001, pp. 128-134
Ziprasidone in the short-term treatment of patients with schizoaffective disorder: Results from two double-blind, placebo-controlled, multicenter studies
Authors: Keck, PE Reeves, KR Harrigan, EP
Citation: Pe. Keck et al., Ziprasidone in the short-term treatment of patients with schizoaffective disorder: Results from two double-blind, placebo-controlled, multicenter studies, J CL PSYCH, 21(1), 2001, pp. 27-35
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term managementof agitated psychotic patients
Authors: Lesem, MD Zajecka, JM Swift, RH Reeves, KR Harrigan, EP
Citation: Md. Lesem et al., Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term managementof agitated psychotic patients, J CLIN PSY, 62(1), 2001, pp. 12-18
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial
Authors: Daniel, DG Zimbroff, DL Potkin, SG Reeves, KR Harrigan, EP Lakshminarayanan, M
Citation: Dg. Daniel et al., Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: A 6-week placebo-controlled trial, NEUROPSYCH, 20(5), 1999, pp. 491-505
Risultati: 1-4 |